Home Tags Illumina

Tag: Illumina

Illumina

The FTC vs. The War On Cancer

By Wall Street Journal Thank you for the editorial “Antitrust’s Unholy Grail” (Sept. 7) on the fate of Illumina’s acquisition of Grail, the firm behind...
Illumina

Illumina Wins Case Against FTC OverGrail Buy

A judge has ruled in favor of Illumina in its acquisition of Grail dealing a blow to the Us Federal Trade Commission's efforts to unwind...
Illumina

EU Antitrust Review Of Illumina $8B Grail Merger Advances

Illumina has failed to block a European Union competition investigation into its $8 billion takeover of liquid biopsy company Grail. The genome-sequencing specialist corporation sought...
Illumina

Illumina Pays To Settle Years-Long Patent Battles

After spending the last 10-plus years in court, Illumina and BGI Group have reached a $325 million settlement to resolve a number of patent...
Illumina

Illumina Loses Challenge Against EU Antitrust Probe

Illumina on Wednesday lost its challenge in Europe's second-highest court against the European Union having scrutiny over its $8 billion cash-and-stock takeover of fellow...
EU

EU To Rule On Illumina’s Challenge Of EU Review Of Grail...

A European court will decide on July 13 whether US life sciences company Illumina’s $8 billion cash-and-stock takeover of Grail should be scrutinised by...
Illumina

EU Not Convinced On Illumina Remedies For Grail Bid

US life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has "yet to convince" EU antitrust regulators...
Illumina

EU Watchdog Pauses Illumina, Grail Probe Again

EU antitrust regulators have temporarily paused their investigation into US life sciences company Illumina bid for $8 billion cash-and-stock takeover of Grail while waiting...
Illumina

Illumina Offers Concessions To EU Over $8B Grail Deal

Illumina has offered to cut prices and continue to allow rivals access to its technologies in a bid to allay EU antitrust concerns about...
Illumina

EU Antitrust Regulators Re-Start Illumina, Grail Probe

EU antitrust regulators have resumed their scrutiny of US life sciences company Illumina’s bid for Grail after a two-month temporary halt and will decide...
Enable Notifications    OK No thanks